1Abraldes J G,,Bosch J.Somatostatin and analogues in portal Hyper-tension. Hepatology . 2002
2Winkfield,B,Aube,C,Burtin,P.Inter-observer and intra-observer variability in hepatology. European Journal of Gastroenterology and Hepatology . 2003
3Pascal JP,Cale s P,Desmorat H.Natural history of oesophageal varices. Recent advances in the pathophysiology and treatment of portal hypertension . 1989
4Bureau C,Peron JM,Alric L,et al."A la carte"treatment of portal hypertension:adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology . 2002
5D. L. Raines, A. W. Dupont†,</a> &,M. R. Arguedas.Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding. Alimentary Pharmacology and Therapeutics . 2004
6Bosch J,Abraldes JG,Groszmann R.Current management of portal hypertension. Journal of Hepatology . 2003
7Merkel C,Bolognesi M,Sacerdoti D,et al.The hemodynamicresponse to medical treatment of portal hypertension as a pre-dictor of clinical ffectiveness in the primary prophylaxis ofvariceal bleeding in cirrhosis. Hepatology . 2000
8Vorobioff J,Bredfeldt JE,Groszmann RJ.Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. American Journal of Physiology . 1983
9Benoit JN,Barrowman JA,Harper SL,et al.Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. American Journal of Physiology . 1984
10Schepis F,Camma C,Niceforo D,et al.Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?. Hepatology . 2001
